{
  "docId": "019de074-2763-7087-8fbd-df19b6e58266",
  "docSlug": "1ca51573de190fbfcf19415b61000ddd",
  "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 18,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "key_messages",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/7",
  "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266",
  "deckJsonHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json",
  "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.82,
        "x": 0.14,
        "y": 0.82
      },
      "kind": "callout",
      "text": "Underpinned by advancements in Data, AI and Digital Health",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5655eaa9-65d8-4bdf-b5ca-a9d38c197f55",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.75,
        "x": 0.18,
        "y": 0.42
      },
      "kind": "list",
      "text": "Small molecules, Antibody therapeutics, Nucleotide-based therapeutics, Cell-based therapeutics, Peptide/protein therapeutics, in vivo-expressed biologics",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "253c2493-6c2b-4073-89de-ba27947154ef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.25,
        "x": 0.18,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "'Growth Through Innovation' investing in four areas to create the greatest and swiftest impact on disease",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e2ab40c-46f3-41ec-bea3-aa1f4a8b0183",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "PROTACS = proteolysis targeting chimeras; ADCs = antibody-drug conjugates; CAR-T = chimeric antigen receptor (CAR) T-cell therapy; Treg = regulatory T-cell; siRNA = small interfering ribonucleic acid; mRNA = modified ribonucleic acid; DNA = deoxyribonucleic acid; AI = artificial intelligence.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77abe851-2132-4868-a593-b0ab3532fd2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Extensive R&D investment in cutting-edge platforms and technology",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "700de6c8-0bcb-4731-9a22-14ad9539fe7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Strengthening scientific leadership",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5f0eb449-4daf-4def-83f3-4eaf841074ee",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "a877eebb-4f9c-42e1-b4d4-6de563c23de5",
      "evidence": "list/bullet: Small molecules, Antibody therapeutics, Nucleotide-based therapeutics, Cell-based therapeutics, Peptide/protein therapeutics, in vivo-expressed biologics",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "Growth Through Innovation",
      "slug": null,
      "matchId": "588de2af-e79a-42f1-862b-7e5563375980",
      "evidence": "Explicitly stated as the strategic framework for R&D investment.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "48ed926e-7814-46ee-a629-10f94cf90551",
      "arcName": "The Golden Circle",
      "arcSlug": "golden-circle",
      "beatName": "KPI Overview",
      "beatSlug": null,
      "evidence": "Financials and KPIs are presented to show strong performance and momentum.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 11,
      "from": 3,
      "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455",
      "arcName": "The Golden Circle",
      "arcSlug": "golden-circle",
      "beatName": "Executive Summary",
      "beatSlug": null,
      "evidence": "Summarizing the company's position and strategy for growth.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "88983257-4d74-4000-ae54-8166a2051abc",
      "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.",
      "position": 0,
      "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.8,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}